To determine whether MDSCs played a role in the progression of cervical cancer, we sought the frequency of tumor-infiltrating MDSCs defined as HLADR−/low CD33+ CD11b+ population (Fig. 1A). The gene discussed is CD33; the disease is cervical carcinoma.